Insource specialist testing without increasing your cost base.
How did Spectrum Health determine that ramping up a new test offering was feasible immediately?
Context: The need for new testing capability
The Spectrum Health Advanced Technology Laboratory (ATL) was performing a feasibility study to establish a Human Leukocyte Antigen (HLA) Typing capability within the current molecular laboratory. The laboratory needed to determine whether it could bring on HLA testing using existing staff.
Approach: Evaluating the impact
Resource data, workforce utilization analytics, the HLA process design and expected service performance were examined. Considering increasing Next-Generation Sequencing (NGS) volumes and additional protocols, it was found that current staff would be sufficient to bring on the new test. The original assumption was that a dedicated HLA laboratory would be required from the outset.
“With the Performance Assurance Report and the PinpointBPS® modeling, we were able to determine that we could utilize existing staff to perform testing for the HLA laboratory start up.”
— Kim Collison, Director of Laboratory Services, Advanced Technology Laboratories, Spectrum Health, Grand Rapids, Michigan
Results: Immediate realization of the opportunity
Unnecessary startup capital investment was avoided.
Opportunity to add new testing capability could be immediately realized.
Additional staff would only be required down the line, if operational volumes increased.